Guess which $4.4 billion ASX mining stock is crashing 14% today

This gold miner is having anything but a golden day on Thursday.

| More on:
A man holds his head in his hands, despairing at the bad result he's reading on his computer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a disappointing session for the SSR Mining Inc (ASX: SSR) share price.

In afternoon trade, the ASX mining stock is down 15% to $18.48. At one stage it hit a 52-week low of $18.29.

This has reduced the gold miner's market capitalisation from $4.4 billion to approximately $3.7 billion.

Why is this ASX mining stock getting hammered?

Investors have been heading to the exits today after the company released its third-quarter results.

According to the release, the gold miner delivered third-quarter production of 192,195 ounces with an all-in sustaining cost (AISC) of US$1,289 per ounce.

This means that year-to-date production is 495,668 ounces with an AISC of US$1,516 per ounce. In light of this, the company believes that it is tracking towards the lower end of its production guidance in 2023.

So why the selling?

Investors may be disappointed because despite this production, its lower AISC, and the strong gold price, it only delivered net income of US$15.2 million for the three months. That's not much for a company of this size.

Management advised that this reflects one-time tax expenses associated with the increase of the corporate income tax rate in Turkey.

On an adjusted basis, its net income would have been much higher at US$53 million for the period.

Another thing that appears to be weighing on the ASX mining stock is the average realised price it commanded for its gold. That came in at US$1,913 per ounce, which was short of the Bloomberg consensus estimate.

Overall, a very messy set of results with positives and negatives.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »